{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:22:13Z","timestamp":1792653733734,"version":"4.5.0"},"reference-count":299,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA195586"],"award-info":[{"award-number":["R01 CA195586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA247471"],"award-info":[{"award-number":["R01CA247471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA213862"],"award-info":[{"award-number":["U01CA213862"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbcan.2021.188554","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T10:38:48Z","timestamp":1619865528000},"page":"188554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Modeling pancreatic cancer in mice for experimental therapeutics"],"prefix":"10.1016","volume":"1876","author":[{"given":"Kavita","family":"Mallya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra K.","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2021.188554_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.bbcan.2021.188554_bb0010","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","article-title":"Early detection of pancreatic cancer: opportunities and challenges","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12916-018-1215-3","article-title":"Pancreatic cancer: challenges and opportunities","volume":"16","author":"Zhu","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41416-019-0479-5","article-title":"Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features","volume":"121","author":"Karamitopoulou","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.05.012","article-title":"Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer","volume":"178","author":"Ligorio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0035","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/1078-0432.CCR-18-3724","article-title":"Mapping physical tumor microenvironment and drug delivery","volume":"25","author":"Nia","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41419-018-1104-x","article-title":"Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1\/SATB-1 pathway in pancreatic cancer","volume":"9","author":"Wei","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2021.188554_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ags3.12225","article-title":"Role of the tumor microenvironment in pancreatic cancer","volume":"3","author":"Murakami","year":"2019","journal-title":"Ann Gastroenterol Surg."},{"key":"10.1016\/j.bbcan.2021.188554_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/bjc.1981.7","article-title":"Growth of human digestive-tumour xenografts in athymic nude rats","volume":"43","author":"Davies","year":"1981","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0055","first-page":"27","article-title":"Experimental pancreatic carcinoma as a model of human pancreatic carcinoma","volume":"10","author":"Satake","year":"1984","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0060","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0022-4804(89)90130-3","article-title":"The nude mouse as a model for the study of human pancreatic cancer","volume":"47","author":"Marincola","year":"1989","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jso.2930400412","article-title":"Invasion and metastasis following orthotopic transplantation of human pancreatic cancer in the nude mouse","volume":"40","author":"Vezeridis","year":"1989","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0039-6060(97)90268-3","article-title":"A rat model of pancreatic ductal adenocarcinoma: targeting chemical carcinogens","volume":"122","author":"Rivera","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0039-6060(99)70099-1","article-title":"An orthotopic in vivo model of human pancreatic cancer","volume":"126","author":"Schwarz","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1272\/jnms.66.253","article-title":"Two types of peritoneal dissemination of pancreatic cancer cells in a hamster model","volume":"66","author":"Yamamura","year":"1999","journal-title":"Nihon Ika Daigaku zasshi"},{"key":"10.1016\/j.bbcan.2021.188554_bb0085","first-page":"887","article-title":"An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies","volume":"4","author":"Mohammad","year":"1998","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb0090","first-page":"3186","article-title":"Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer","volume":"7","author":"Cardillo","year":"2001","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb0095","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.7150\/jca.37529","article-title":"Progress in animal models of pancreatic ductal adenocarcinoma","volume":"11","author":"Kong","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0100","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","article-title":"A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens","volume":"89","author":"Fu","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188554_bb0105","first-page":"3070","article-title":"A novel \"patient-like\" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice","volume":"53","author":"Furukawa","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers12051327","article-title":"Patient-derived xenograft models of pancreatic cancer: overview and comparison with other types of models","volume":"12","author":"Garcia","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2021.188554_bb0115","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/1078-0432.CCR-17-1115","article-title":"Treatment of pancreatic cancer patient\u2013derived xenograft panel with metabolic inhibitors reveals efficacy of phenformin","volume":"23","author":"Rajeshkumar","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0120","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.celrep.2016.07.023","article-title":"Integrated patient-derived models delineate individualized therapeutic vulnerabilities of pancreatic cancer","volume":"16","author":"Agnieszka","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb0125","first-page":"627","article-title":"A clinical nude mouse metastatic model for highly malignant human pancreatic cancer","volume":"16","author":"An","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02787375","article-title":"Establishment of an experimental liver metastasis model by intraportal injection of a newly derived human pancreatic cancer cell line (KLM-1)","volume":"20","author":"Kimura","year":"1996","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0039-6060(98)70114-X","article-title":"Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene","volume":"124","author":"Hwang","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0140","doi-asserted-by":"crossref","first-page":"102070","DOI":"10.1016\/j.ctrv.2020.102070","article-title":"KRAS: from undruggable to a druggable cancer target","volume":"89","author":"Uprety","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2021.188554_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0150","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/35074129","article-title":"Somatic activation of the K-ras oncogene causes early onset lung cancer in mice","volume":"410","author":"Johnson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2021.188554_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0165","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1172\/JCI62385","article-title":"Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker","volume":"122","author":"Ray","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2021.188554_bb0170","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1158\/1078-0432.CCR-13-3474","article-title":"Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer","volume":"21","author":"Mirus","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0175","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/bjc.2015.370","article-title":"Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models","volume":"113","author":"Ligat","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0180","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708741","article-title":"Soluble stroma-related biomarkers of pancreatic cancer","volume":"10","author":"Resovi","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb0185","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","article-title":"JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice","volume":"154","author":"Song","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2018-317424","article-title":"Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion","volume":"69","author":"Jiang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb0195","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1158\/0008-5472.CAN-18-0634","article-title":"Inverse correlation of STAT3 and MEK signaling mediates resistance to RAS pathway inhibition in pancreatic cancer","volume":"78","author":"Nagathihalli","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0200","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-06-0436","article-title":"The use of targeted mouse models for preclinical testing of novel cancer therapeutics","volume":"12","author":"Olive","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0205","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti\u2013PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb0215","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/j.gastro.2013.01.020","article-title":"Vaccination With ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer","volume":"144","author":"Cappello","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0220","doi-asserted-by":"crossref","first-page":"43005","DOI":"10.18632\/oncotarget.5656","article-title":"TGF-\u03b2 blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner","volume":"6","author":"Soares","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2021.188554_bb0225","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.02.055","article-title":"A listeria vaccine and depletion of t-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice","volume":"146","author":"Keenan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0230","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2021.188554_bb0235","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1158\/0008-5472.CAN-17-2320","article-title":"Inactivation of cancer-associated-fibroblasts disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression","volume":"78","author":"Dauer","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080580","article-title":"Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy","volume":"8","author":"Torres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2021.188554_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gde.2019.02.003","article-title":"Organoid models for translational pancreatic cancer research","volume":"54","author":"Tiriac","year":"2019","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbcan.2021.188554_bb0250","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0255","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.csbj.2019.03.016","article-title":"Mouse-derived allografts: a complementary model to the KPC mice on researching pancreatic cancer in vivo","volume":"17","author":"Li","year":"2019","journal-title":"Computat. Structural Biotechnol. J."},{"issue":"2018","key":"10.1016\/j.bbcan.2021.188554_bb0265","article-title":"The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression","volume":"17","author":"Wallez","year":"1670","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2021.188554_bb0270","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aaw3145","article-title":"The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice","volume":"364","author":"Engle","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2021.188554_bb0275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb0280","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40425-019-0601-5","article-title":"Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies","volume":"7","author":"Kim","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02030","article-title":"Radiation and local Anti-CD40 generate an effective in situ vaccine in preclinical models of pancreatic cancer","volume":"9","author":"Yasmin-Karim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0290","first-page":"2456","article-title":"Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma","volume":"9","author":"Yang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.gastro.2020.03.018","article-title":"Combination of PD1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer","volume":"159","author":"Ma","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0300","first-page":"167","article-title":"PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy","volume":"9","author":"Azad","year":"2017","journal-title":"EMBOMmol. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb0305","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1172\/JCI123540","article-title":"Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer","volume":"129","author":"Sivaram","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2021.188554_bb0310","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99573","article-title":"Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses","volume":"3","author":"Watanabe","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2021.188554_bb0315","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41587-019-0398-2","article-title":"Interleukin-23 engineering improves CAR T cell function in solid tumors","volume":"38","author":"Ma","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0320","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2021.188554_bb0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2021.188554_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-017-0701-0","article-title":"Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer","volume":"16","author":"Chen","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0335","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1038\/ncomms13496","article-title":"Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic \u03b2-cells","volume":"7","author":"Brereton","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188554_bb0340","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2337\/db14-1132","article-title":"Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms","volume":"64","author":"Cifarelli","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbcan.2021.188554_bb0345","doi-asserted-by":"crossref","first-page":"38539","DOI":"10.18632\/oncotarget.9533","article-title":"Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2021.188554_bb0350","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.18632\/oncotarget.6820","article-title":"HDAC3 mediates smoking-induced pancreatic cancer","volume":"7","author":"Edderkaoui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2021.188554_bb0355","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/onc.2014.154","article-title":"Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages","volume":"34","author":"Kumar","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb0360","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/MPA.0000000000000380","article-title":"Characterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic Pancreatitis","volume":"44","author":"Xu","year":"2015","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.bbcan.2021.188554_bb0365","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/17460441.2019.1566319","article-title":"Animal models for modeling pancreatic cancer and novel drug discovery","volume":"14","author":"Bisht","year":"2019","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0375","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2013.01.070","article-title":"Relevance of animal models of pancreatic cancer and pancreatitis to human disease","volume":"144","author":"Saluja","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0380","first-page":"375","article-title":"Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma","volume":"4","author":"Kalapothaki","year":"1993","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbcan.2021.188554_bb0385","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Maisonneuve","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0390","first-page":"283","article-title":"Discovering the route from inflammation to pancreatic cancer","volume":"58","author":"Momi","year":"2012","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0395","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000001357","article-title":"The relationship of acute pancreatitis and pancreatic cancer","volume":"48","author":"Li","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2021.188554_bb0400","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ncpgasthep0881","article-title":"Mechanisms of Disease: chronic inflammation and cancer in the pancreas\u2014a potential role for pancreatic stellate cells?","volume":"4","author":"Alg\u00fcl","year":"2007","journal-title":"Nat. Cli. Practice Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0405","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1096\/fj.201800241RR","article-title":"Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison","volume":"32","author":"Klauss","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2021.188554_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.48","article-title":"Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer","volume":"83","author":"Leal","year":"2018","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0415","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2012.12.043","article-title":"Models of Acute and Chronic Pancreatitis","volume":"144","author":"Lerch","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00432156","article-title":"Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue, Virchows Archiv. A","volume":"373","author":"Lampel","year":"1977","journal-title":"Pathol. Anat. Histol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0425","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/onc.2016.461","article-title":"Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53","volume":"36","author":"Swidnicka-Siergiejko","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb0430","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5114\/ceji.2016.58816","article-title":"An optimised mouse model of chronic pancreatitis with a combination of ethanol and cerulein","volume":"41","author":"Ahmadi","year":"2016","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0435","series-title":"CXCR2 inhibition suppresses acute and chronic pancreatic inflammation","first-page":"85","volume":"237","author":"Steele","year":"2015"},{"key":"10.1016\/j.bbcan.2021.188554_bb0440","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41598-017-01973-0","article-title":"Inhibition of Jak\/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo","volume":"7","author":"Komar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb0445","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","article-title":"Phenotype and genotype of pancreatic cancer cell lines","volume":"39","author":"Deer","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2021.188554_bb0450","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000001420","article-title":"Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line","volume":"48","author":"Kim","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2021.188554_bb0455","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gutjnl-2016-313133","article-title":"Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility","volume":"67","author":"Knudsen","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01443","article-title":"Upcoming revolutionary paths in preclinical modeling of pancreatic adenocarcinoma","volume":"9","author":"Swayden","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0465","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/carcin\/bgx040","article-title":"Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice","volume":"38","author":"Moriya","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2021.188554_bb0470","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.sla.0000140755.97224.9a","article-title":"Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer","volume":"240","author":"Duxbury","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2021.188554_bb0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2019.11.028","article-title":"Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer","volume":"470","author":"Morimoto","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0480","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1535-7163.MCT-19-0270","article-title":"Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer","volume":"19","author":"Santoro","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2021.188554_bb0485","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-020-2242-5","article-title":"NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter","volume":"11","author":"Lee","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2021.188554_bb0490","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1158\/1541-7786.MCR-19-0741","article-title":"Combined Src\/EGFR inhibition targets STAT3 signaling and induces stromal remodeling to improve survival in pancreatic cancer","volume":"18","author":"Dosch","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0495","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1073\/pnas.1314307110","article-title":"Mutant KRAS is a druggable target for pancreatic cancer","volume":"110","author":"Zorde Khvalevsky","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb0500","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/s41388-019-1102-1","article-title":"Chemotherapy impacts on the cellular response to CDK4\/6 inhibition: distinct mechanisms of interaction and efficacy in models of pancreatic cancer","volume":"39","author":"Kumarasamy","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb0505","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/gutjnl-2018-317856","article-title":"SUMO pathway inhibition targets an aggressive pancreatic cancer subtype","volume":"69","author":"Biederst\u00e4dt","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb0510","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1158\/0008-5472.CAN-19-3094","article-title":"Dual oxidase-induced sustained generation of hydrogen peroxide contributes to pharmacologic ascorbate-induced cytotoxicity","volume":"80","author":"Gibson","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0515","doi-asserted-by":"crossref","first-page":"e129905","DOI":"10.1172\/jci.insight.129905","article-title":"Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU\/FOLFOX chemotherapy","volume":"5","author":"Lipner","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2021.188554_bb0520","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1038\/s41388-020-1260-1","article-title":"Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation","volume":"39","author":"Ricciardiello","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb0525","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2021.188554_bb0530","first-page":"3055","article-title":"Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0535","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1053\/j.gastro.2018.12.044","article-title":"Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets","volume":"156","author":"Whittle","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0540","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/s41598-020-62416-x","article-title":"Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes","volume":"10","author":"Pausch","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102786","article-title":"Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses","volume":"56","author":"Raimondi","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2021.188554_bb0550","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb0555","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1158\/1078-0432.CCR-09-2384","article-title":"Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host","volume":"16","author":"Tseng","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0560","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-20-0133","article-title":"Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes","volume":"10","author":"Miyabayashi","year":"2020","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0565","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50740","article-title":"Preclinical murine tumor models: A structural and functional perspective","volume":"9","author":"Guerin","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.bbcan.2021.188554_bb0570","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.034793","article-title":"Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy","volume":"11","author":"Erstad","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbcan.2021.188554_bb0575","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3748\/wjg.v18.i12.1286","article-title":"Mouse models of pancreatic cancer","volume":"18","author":"Herreros-Villanueva","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0580","doi-asserted-by":"crossref","first-page":"11117","DOI":"10.1038\/s41598-019-47308-z","article-title":"Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb0585","doi-asserted-by":"crossref","first-page":"30670","DOI":"10.1073\/pnas.1920240117","article-title":"Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma","volume":"117","author":"Grbovic-Huezo","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb0590","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijrobp.2016.09.005","article-title":"In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1\u03b1 Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model","volume":"97","author":"Maeda","year":"2017","journal-title":"Int. J. Radiation Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0595","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nprot.2012.053","article-title":"Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection","volume":"7","author":"Fridman","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbcan.2021.188554_bb0600","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ijc.25781","article-title":"Multiple uses of basement membrane-like matrix (BME\/Matrigel) in vitro and in vivo with cancer cells","volume":"128","author":"Benton","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.07.059","article-title":"Combination PD-1 and PD-L1 blockade promotes durable neoantigen-specific T cell-mediated immunity in pancreatic ductal adenocarcinoma","volume":"28","author":"Burrack","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb0610","first-page":"e60497","article-title":"Ultrasound-guided orthotopic implantation of murine pancreatic ductal adenocarcinoma","author":"Hay","year":"2019","journal-title":"JoVE"},{"key":"10.1016\/j.bbcan.2021.188554_bb0615","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1038\/s41598-019-46410-6","article-title":"Development of orthotopic tumour models using ultrasound-guided intrahepatic injection","volume":"9","author":"McVeigh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb0620","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2011.12.021","article-title":"Neoptolemos, understanding metastasis in pancreatic cancer: a call for new clinical approaches","volume":"148","author":"David","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0625","series-title":"The Pathology and Genetics of Metastatic Pancreatic Cancer","first-page":"413","volume":"133","author":"Yachida","year":"2009"},{"key":"10.1016\/j.bbcan.2021.188554_bb0630","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jss.2004.02.014","article-title":"Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model","volume":"120","author":"B\u00fcchler","year":"2004","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0635","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/B:CLIN.0000017160.93812.3b","article-title":"An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer","volume":"21","author":"Katz","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2021.188554_bb0640","first-page":"3091","article-title":"Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mouse model","volume":"15","author":"Higuchi","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0645","first-page":"51677","article-title":"A preclinical murine model of hepatic metastases","volume":"91","author":"Soares","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbcan.2021.188554_bb0650","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1158\/0008-5472.CAN-06-0339","article-title":"Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells","volume":"66","author":"Enomoto","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0655","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1245\/s10434-016-5515-6","article-title":"Impact of portal vein involvement from pancreatic cancer on metastatic pattern after surgical resection","volume":"23","author":"Mierke","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0660","article-title":"A portal vein injection model to study liver metastasis of breast cancer","volume":"54903","author":"Goddard","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbcan.2021.188554_bb0665","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1158\/0008-5472.CAN-06-0339","article-title":"Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells","volume":"66","author":"Enomoto","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0670","doi-asserted-by":"crossref","first-page":"G682","DOI":"10.1152\/ajpgi.00209.2015","article-title":"Selective portal vein injection for the design of syngeneic models of liver malignancy","volume":"310","author":"Limani","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0675","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12967-020-02377-x","article-title":"Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma","volume":"18","author":"Sugase","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0685","first-page":"1","article-title":"Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche","volume":"9","author":"Chen","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0690","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41388-020-01578-4","article-title":"Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma","volume":"40","author":"Tan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb0695","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc3131","article-title":"Perineural invasion and associated pain in pancreatic cancer","volume":"11","author":"Bapat","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0700","first-page":"719","article-title":"Perineural invasion of pancreas head carcinoma","volume":"84","author":"Matsuda","year":"1983","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"10.1016\/j.bbcan.2021.188554_bb0705","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0016-5085(91)90226-B","article-title":"Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications","volume":"100","author":"Pour","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0710","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/B:CLIN.0000046131.24625.54","article-title":"Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells","volume":"21","author":"Okada","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2021.188554_bb0715","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1158\/0008-5472.CAN-06-2483","article-title":"MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion","volume":"67","author":"Swanson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0720","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mehy.2008.05.001","article-title":"Hyperglycemia promotes the perineural invasion in pancreatic cancer","volume":"71","author":"Li","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbcan.2021.188554_bb0725","first-page":"1111","article-title":"The microtubule-associated protein MAPRE2 is involved in perineural invasion of pancreatic cancer cells","volume":"35","author":"Abiatari","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0730","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1245\/s10434-010-0955-x","article-title":"Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma","volume":"17","author":"Ben","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0735","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/1541-7786.MCR-12-0609","article-title":"Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells","volume":"11","author":"Li","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0740","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.7150\/thno.24281","article-title":"MMP1\/PAR1\/SP\/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells","volume":"8","author":"Huang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2021.188554_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051294","article-title":"A novel role of interleukin 13 receptor alpha2 in perineural invasion and its association with poor prognosis of patients with pancreatic ductal adenocarcinoma","volume":"12","author":"Fujisawa","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2021.188554_bb0750","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MPA.0000000000001506","article-title":"Tenascin C in the tumor-nerve microenvironment enhances perineural invasion and correlates with locoregional recurrence in pancreatic ductal adenocarcinoma","volume":"49","author":"Furuhashi","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2021.188554_bb0755","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2021.03.016","article-title":"CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT\/EGR-1\/GDNF axis in pancreatic ductal adenocarcinoma","volume":"508","author":"Zhang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0760","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.mpa.0000175176.40045.0f","article-title":"A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer","volume":"31","author":"Eibl","year":"2005","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2021.188554_bb0765","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-05-1852","article-title":"Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer","volume":"12","author":"Koide","year":"2006","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb0770","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.1512603113","article-title":"Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer","volume":"113","author":"Saloman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188554_bb0775","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.05.065","article-title":"Axon guidance molecules promote perineural invasion and metastasis of orthotopic pancreatic tumors in mice","volume":"157","author":"Jurcak","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0780","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","article-title":"Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma","volume":"80","author":"Yang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0785","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2021.188554_bb0790","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1073\/pnas.1300415110","article-title":"CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer","volume":"110","author":"Neesse","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188554_bb0795","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188554_bb0800","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-019-1225-9","article-title":"Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells","volume":"38","author":"Hwang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0805","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-019-1130-6","article-title":"Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring","volume":"569","author":"Shi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2021.188554_bb0810","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/labinvest.2017.127","article-title":"Experimental models of pancreatic cancer desmoplasia","volume":"98","author":"Suklabaidya","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2021.188554_bb0815","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","article-title":"Fibroblast heterogeneity in the pancreatic tumor microenvironment","volume":"10","author":"Helms","year":"2020","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb0820","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/labinvest.2017.127","article-title":"Experimental models of pancreatic cancer desmoplasia","volume":"98","author":"Suklabaidya","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2021.188554_bb0825","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmolb.2019.00070","article-title":"Impact of cancer-associated fibroblast on the radiation-response of solid xenograft tumors","volume":"6","author":"Steer","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbcan.2021.188554_bb0830","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jamcollsurg.2014.07.311","article-title":"MicroRNAs in pancreatic fibroblast induced by tumor cells","volume":"219","author":"Nguyen","year":"2014","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.bbcan.2021.188554_bb0835","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb0840","first-page":"519462","article-title":"Targeting tumor-intrinsic metabolic node sensitizes pancreatic cancer to anti-PD1 therapy","author":"Sharma","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbcan.2021.188554_bb0845","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI127515","article-title":"Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy","volume":"130","author":"Sharma","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2021.188554_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182855","article-title":"Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival","volume":"12","author":"Pergolini","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2021.188554_bb0855","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2007.09.009","article-title":"In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia","volume":"133","author":"Strobel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0860","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1242\/dev.053843","article-title":"Lineage tracing reveals the dynamic contribution of cells to the developing and adult pancreas","volume":"138","author":"Kopinke","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2021.188554_bb0865","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0925-4773(02)00330-1","article-title":"Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis","volume":"120","author":"Gu","year":"2003","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbcan.2021.188554_bb0870","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0875","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.gastro.2013.09.050","article-title":"DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer","volume":"146","author":"Bailey","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0880","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.stem.2016.03.016","article-title":"Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesis","volume":"18","author":"Westphalen","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0885","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2018.03.009","article-title":"Pancreatic DCLK1(+) cells originate distinctly from PDX1(+) progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice","volume":"423","author":"Qiu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0890","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1038\/onc.2013.514","article-title":"Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma","volume":"33","author":"Glenn","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb0895","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41467-017-01967-6","article-title":"MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance","volume":"8","author":"Farrell","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188554_bb0900","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.12.007","article-title":"Loss of Pten and activation of kras synergistically induce formation of intraductal papillary mucinous neoplasia from pancreatic ductal cells in mice","volume":"154","author":"Kopp","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0905","doi-asserted-by":"crossref","first-page":"20679","DOI":"10.1073\/pnas.1901075116","article-title":"Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer","volume":"116","author":"Mameishvili","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188554_bb0910","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","article-title":"Biology of cachexia","volume":"89","author":"Tisdale","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2021.188554_bb0915","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/MPA.0000000000001124","article-title":"Pancreatic cancer-induced cachexia and relevant mouse models","volume":"47","author":"Henderson","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2021.188554_bb0920","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1997.17","article-title":"Changes in nutritional status associated with unresectable pancreatic cancer","volume":"75","author":"Wigmore","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.advms.2013.11.001","article-title":"Anorexia-cachexia syndrome in pancreatic cancer: recent advances and new pharmacological approach","volume":"59","author":"Ronga","year":"2014","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb0930","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2021.188554_bb0935","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3748\/wjg.v9.i7.1567","article-title":"Role of NF-kappaB and cytokine in experimental cancer cachexia","volume":"9","author":"Zhou","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2021.188554_bb0940","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2021.188554_bb0945","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132786","article-title":"TGF-beta blockade reduces mortality and metabolic changes in a validated murine model of pancreatic cancer cachexia","volume":"10","author":"Greco","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2021.188554_bb0950","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4240\/wjgs.v10.i9.95","article-title":"Molecular therapeutic strategies targeting pancreatic cancer induced cachexia","volume":"10","author":"Yakovenko","year":"2018","journal-title":"World J. Gastrointest. Surg."},{"key":"10.1016\/j.bbcan.2021.188554_bb0955","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12967-018-1673-6","article-title":"CD25 and TGF-beta blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer","volume":"16","author":"Pu","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb0960","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcsm.12377","article-title":"MyD88 signalling is critical in the development of pancreatic cancer cachexia","volume":"10","author":"Zhu","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2021.188554_bb0965","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcsm.12225","article-title":"Establishment and characterization of a novel murine model of pancreatic cancer cachexia","volume":"8","author":"Michaelis","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2021.188554_bb0970","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.80","article-title":"Preclinical models for studying the impact of macrophages on cancer cachexia","volume":"91","author":"Markov","year":"2020","journal-title":"Current Protocols in Pharmacology"},{"key":"10.1016\/j.bbcan.2021.188554_bb0975","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","article-title":"Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia","volume":"484","author":"Shukla","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0980","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1535-6108(03)00337-4","article-title":"Mouse models of pancreatic cancer: the fur is finally flying!","volume":"5","author":"Leach","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb0985","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2013.07.010","article-title":"The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models","volume":"339","author":"Shen","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb0990","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0b013e31827ab4c4","article-title":"Genetically engineered mouse models of pancreatic cancer","volume":"18","author":"Westphalen","year":"2012","journal-title":"Cancer J."},{"key":"10.1016\/j.bbcan.2021.188554_bb0995","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molonc.2013.02.002","article-title":"Genetically engineered mouse models of pancreatic adenocarcinoma","volume":"7","author":"Guerra","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1000","doi-asserted-by":"crossref","first-page":"e07125","DOI":"10.7554\/eLife.07125","article-title":"The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma","volume":"4","author":"Krah","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.bbcan.2021.188554_bb1005","article-title":"LSL-KrasG12D; LSL-Trp53R172H\/+; Ink4flox\/+; Ptf1\/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2021.188554_bb1010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/bjc.2017.216","article-title":"HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer","volume":"117","author":"Veite-Schmahl","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb1015","article-title":"High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer","author":"Feng","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbcan.2021.188554_bb1020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1101\/gad.232082.113","article-title":"A modular and flexible ESC-based mouse model of pancreatic cancer","volume":"28","author":"Saborowski","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2021.188554_bb1025","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.07.036","article-title":"Inhibition of aurora kinase a induces necroptosis in pancreatic carcinoma","volume":"153","author":"Xie","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb1030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/2159-8290.CD-18-1409","article-title":"Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer","volume":"9","author":"Humpton","year":"2019","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb1035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/carcin\/bgx043","article-title":"Nrf2 promotes mutant K-ras\/p53-driven pancreatic carcinogenesis","volume":"38","author":"Hamada","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2021.188554_bb1040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ymthe.2018.11.012","article-title":"Nanoparticle delivery of RIG-I agonist enables effective and safe adjuvant therapy in pancreatic cancer","volume":"27","author":"Das","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2021.188554_bb1045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41388-018-0458-y","article-title":"L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression","volume":"38","author":"Na'ara","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb1050","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1053\/j.gastro.2018.08.007","article-title":"Disruption of C1galt1 gene promotes development and metastasis of pancreatic adenocarcinomas in mice","volume":"155","author":"Chugh","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb1055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ncb3513","article-title":"The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Krebs","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1060","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12514","article-title":"Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1","volume":"52","author":"Zhou","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbcan.2021.188554_bb1065","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.05.041","article-title":"Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1","volume":"155","author":"Nimmakayala","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb1070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neo.2019.11.001","article-title":"Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer","volume":"22","author":"Gupta","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2021.188554_bb1075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41388-020-01518-2","article-title":"Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma","volume":"40","author":"Nimmakayala","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2021.188554_bb1080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2007.01.017","article-title":"Kras(G12D) and Smad4\/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas","volume":"11","author":"Izeradjene","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb1085","first-page":"15","article-title":"K-ras-driven engineered mouse models for pancreatic cancer","volume":"19","author":"Yin","year":"2015","journal-title":"Discov. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb1090","doi-asserted-by":"crossref","first-page":"eabb9200","DOI":"10.1126\/sciadv.abb9200","article-title":"ACSL3\u2013PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression","volume":"6","author":"Rossi Sebastiano","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2021.188554_bb1095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020395118","article-title":"IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions","volume":"118","author":"Mucciolo","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb1100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40644-018-0172-6","article-title":"Evaluation of pancreatic tumor development in KPC mice using multi-parametric MRI","volume":"18","author":"Vohra","year":"2018","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.bbcan.2021.188554_bb1105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2017.10.029","article-title":"Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent","volume":"152","author":"Kawano","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2021.188554_bb1110","first-page":"56979","article-title":"Utilizing high resolution ultrasound to monitor tumor onset and growth in genetically engineered pancreatic cancer models","volume":"134","author":"Goetze","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbcan.2021.188554_bb1115","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.05.004","article-title":"Administration of gemcitabine after pancreatic tumor resection in mice induces an antitumor immune response mediated by natural killer cells","volume":"151","author":"G\u00fcrlevik","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb1120","article-title":"The IL-17A\/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2021.188554_bb1125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231745","article-title":"Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma","volume":"15","author":"Fanchon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2021.188554_bb1140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","article-title":"nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer","volume":"2","author":"Frese","year":"2012","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb1145","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1245\/s10434-020-08782-2","article-title":"Electrochemotherapy with irreversible electroporation and FOLFIRINOX improves survival in murine models of pancreatic adenocarcinoma","volume":"27","author":"Bhutiani","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11307-017-1078-6","article-title":"In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models","volume":"19","author":"Russell","year":"2017","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1155","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gutjnl-2013-305559","article-title":"SPARC independent drug delivery and antitumour effects paclitaxel in genetically engineered mice","volume":"63","author":"Neesse","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb1160","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1158\/1078-0432.CCR-05-0627","article-title":"Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects","volume":"11","author":"Blanquicett","year":"2005","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb1165","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.20004","article-title":"Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft","volume":"109","author":"Gold","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb1170","first-page":"3269","article-title":"Wortmannin inhibits pkb\/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice","volume":"7","author":"Ng","year":"2001","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb1175","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-05-0459","article-title":"Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb1180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11605-015-3000-3","article-title":"Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer","volume":"20","author":"Modi","year":"2016","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.bbcan.2021.188554_bb1185","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1158\/0008-5472.CAN-05-1330","article-title":"Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer","volume":"65","author":"Banerjee","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1190","first-page":"5743s","article-title":"Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer","volume":"55","author":"Alisauskus","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<660::AID-IJC24>3.0.CO;2-E","article-title":"Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4","volume":"71","author":"Gold","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb1200","first-page":"179","article-title":"Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2","volume":"6","author":"Yamamoto","year":"1999","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb1205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1667\/RR15346.1","article-title":"Reoxygenation and repopulation of tumor cells after ablative hypofractionated radiotherapy (SBRT and SRS) in murine tumors","volume":"192","author":"Song","year":"2019","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.2018.36.4_suppl.273","article-title":"Effect of stereotactic radiation (SBRT) on survival in a preclinical model of spontaneous pancreatic cancer with induction gemcitabine\/nab-paclitaxel","volume":"36","author":"Taniguchi","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1215","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00066-018-1326-y","article-title":"MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model","volume":"194","author":"Dobiasch","year":"2018","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1220","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/s41598-019-57364-0","article-title":"Quantifying reoxygenation in pancreatic cancer during stereotactic body radiotherapy","volume":"10","author":"Taylor","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb1225","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.21037\/jgo.2018.05.16","article-title":"Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle","volume":"9","author":"Gajiwala","year":"2018","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.08.095","article-title":"Stereotactic body radiation and Interleukin-12 combination therapy eradicates pancreatic tumors by repolarizing the immune microenvironment","volume":"29","author":"Mills","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb1235","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-17-3821","article-title":"Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer","volume":"78","author":"Rech","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1240","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","article-title":"Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial","volume":"5","author":"Theelen","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1245","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3389\/fimmu.2018.02030","article-title":"Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer","volume":"9","author":"Yasmin-Karim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02030","article-title":"Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer","volume":"9","author":"Yasmin-Karim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/0008-5472.CAN-17-2415","article-title":"Perioperative, spatiotemporally coordinated activation of T and NK cells prevents recurrence of pancreatic cancer","volume":"78","author":"Brooks","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1260","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2967\/jnumed.118.225045","article-title":"(64)Cu-intraperitoneal radioimmunotherapy: a novel approach for adjuvant treatment in a clinically relevant preclinical model of pancreatic cancer","volume":"60","author":"Yoshii","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb1265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-020-01796-4","article-title":"Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation","volume":"39","author":"Pfitzinger","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1270","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1053\/j.gastro.2018.12.038","article-title":"Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities","volume":"156","author":"Balachandran","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2021.188554_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.10.006","article-title":"RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer","volume":"34","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb1280","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2015.09.022","article-title":"T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma","volume":"28","author":"Stromnes","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb1285","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2018-316595","article-title":"Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma","volume":"68","author":"Raj","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb1290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122857","article-title":"Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer","volume":"3","author":"Kinkead","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2021.188554_bb1295","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1242\/dmm.021055","article-title":"GEMMs as preclinical models for testing pancreatic cancer therapies","volume":"8","author":"Gopinathan","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbcan.2021.188554_bb1300","doi-asserted-by":"crossref","first-page":"14.39.11","DOI":"10.1002\/cpph.2","article-title":"Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D\/+);LSL-Trp53(R172H\/+);Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery","volume":"73","author":"Lee","year":"2016","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1305","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1158\/1078-0432.CCR-06-0544","article-title":"Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine","volume":"12","author":"Kimura","year":"2006","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb1310","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1593\/neo.111602","article-title":"In pancreatic carcinoma, dual EGFR\/HER2 targeting with cetuximab\/trastuzumab is more effective than treatment with trastuzumab\/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption","volume":"14","author":"Larbouret","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2021.188554_bb1315","doi-asserted-by":"crossref","unstructured":"L.C. DeRosier, Z.Q. Huang, J.C. Sellers, D.J. Buchsbaum, S.M. Vickers, Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo, J. Gastrointest. Surg., 10 (2006) 1291-1300; discussion 1300.","DOI":"10.1016\/j.gassur.2006.08.007"},{"key":"10.1016\/j.bbcan.2021.188554_bb1320","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1535-7163.MCT-07-0299","article-title":"TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth","volume":"6","author":"Derosier","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2021.188554_bb1325","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.cdd.4402306","article-title":"Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5","volume":"15","author":"Adams","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2021.188554_bb1330","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00262-006-0135-9","article-title":"PankoMab: a potent new generation anti-tumour MUC1 antibody","volume":"55","author":"Danielczyk","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2021.188554_bb1335","first-page":"20","article-title":"Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin","volume":"7","author":"Hassan","year":"2007","journal-title":"Cancer Immun."},{"key":"10.1016\/j.bbcan.2021.188554_bb1340","article-title":"IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor","volume":"13","author":"Rowinsky","year":"2007","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb1345","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/1078-0432.CCR-06-0441","article-title":"Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin. CancerRres."},{"key":"10.1016\/j.bbcan.2021.188554_bb1350","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2021.188554_bb1355","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188554_bb1360","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fonc.2019.00330","article-title":"Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Dreau","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1365","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5625\/lar.2017.33.2.119","article-title":"Use of C57BL\/6N mice on the variety of immunological researches","volume":"33","author":"Song","year":"2017","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1370","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock (Augusta, Ga.)"},{"key":"10.1016\/j.bbcan.2021.188554_bb1375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2017.12.012","article-title":"Emerging trends in the immunotherapy of pancreatic cancer","volume":"417","author":"Banerjee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188554_bb1380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcyt.2019.12.001","article-title":"Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model","volume":"22","author":"Shangguan","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbcan.2021.188554_bb1385","doi-asserted-by":"crossref","first-page":"102016","DOI":"10.1016\/j.ctrv.2020.102016","article-title":"Immunotherapy for pancreatic cancer: A 2020 update","volume":"86","author":"Schizas","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2021.188554_bb1390","doi-asserted-by":"crossref","first-page":"101391","DOI":"10.1016\/j.smim.2020.101391","article-title":"MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy","volume":"47","author":"Gautam","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1395","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18632\/genesandcancer.189","article-title":"Amphiphilic polyanhydride-based recombinant MUC4\u03b2-nanovaccine activates dendritic cells","volume":"10","author":"Banerjee","year":"2019","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2021.188554_bb1400","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2021.188554_bb1405","article-title":"Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity","volume":"154","author":"Spear","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbcan.2021.188554_bb1410","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/13.2.233","article-title":"Influence of organ site and tumor cell type on MUC1-specific tumor immunity","volume":"13","author":"Morikane","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbcan.2021.188554_bb1415","first-page":"315","article-title":"Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model","volume":"58","author":"Rowse","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1420","doi-asserted-by":"crossref","first-page":"33612","DOI":"10.1038\/srep33612","article-title":"Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188554_bb1425","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/21645515.2015.1103405","article-title":"Generation of human MHC (HLA-A11\/DR1) transgenic mice for vaccine evaluation","volume":"12","author":"Zeng","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bbcan.2021.188554_bb1430","doi-asserted-by":"crossref","first-page":"w13914","DOI":"10.4414\/smw.2014.13914","article-title":"A revival of parabiosis in biomedical research","volume":"144","author":"Eggel","year":"2014","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.bbcan.2021.188554_bb1435","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/acel.12065","article-title":"Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity","volume":"12","author":"Conboy","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb1440","first-page":"121","article-title":"Parabiosis and Tumor Growth","volume":"10","author":"Kross","year":"1921","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188554_bb1445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188554_bb1450","doi-asserted-by":"crossref","first-page":"w14678","DOI":"10.4414\/smw.2018.14678","article-title":"The immune influence of a parabiosis model on tumour-bearing mice","volume":"148","author":"Feng","year":"2018","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.bbcan.2021.188554_bb1455","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1600363113","article-title":"Tumor-associated fibroblasts predominantly come from local and not circulating precursors","volume":"113","author":"Arina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188554_bb1460","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1567","article-title":"Determining Leukocyte Origins Using Parabiosis in the PyMT Breast Tumor Model","volume":"5","author":"Franklin","year":"2015","journal-title":"Bio Protoc"},{"key":"10.1016\/j.bbcan.2021.188554_bb1465","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3181\/00379727-115-29075","article-title":"Island-Cell Tumors in Irradiated Rats in Parabiosis","volume":"115","author":"Warren","year":"1964","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.bbcan.2021.188554_bb1470","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1593\/neo.07742","article-title":"Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice","volume":"9","author":"Nakamura","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2021.188554_bb1475","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2017.08.018","article-title":"Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2021.188554_bb1480","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2017-314426","article-title":"Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma","volume":"68","author":"Lee","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2021.188554_bb1485","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/2159-8290.CD-15-0120","article-title":"Pancreatic Cancer Metastases Harbor Evidence of Polyclonality","volume":"5","author":"Maddipati","year":"2015","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bbcan.2021.188554_bb1490","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"I. Australian Pancreatic Cancer Genome, Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2021.188554_bb1495","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X21000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X21000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:40:32Z","timestamp":1759639232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X21000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":299,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0304419X21000512"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188554","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling pancreatic cancer in mice for experimental therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188554"}}